Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Biochem J ; 352 Pt 2: 425-33, 2000 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-11085936

RESUMEN

Phosphorylation of protein kinase C (PKC) provides an amplitude control that operates in conjunction with allosteric effectors. Under many conditions, PKC isotypes appear to be highly phosphorylated; however, the cellular inputs that maintain these phosphorylations are not characterized. In the present work, it is shown that there is a differential phosphorylation of PKCdelta in adherent versus suspension cultures of transfected HEK-293 cells. It is established that integrin activation is sufficient to trigger PKCdelta phosphorylation and that this signals through phosphoinositide 3-kinase (PI3-kinase) to stimulate the phosphorylation of two sites, T505 and S662. The loss of signal input to PKCdelta in suspension culture is dependent on the tumour suppressor gene PTEN, which encodes a bi-functional phosphotyrosine/phosphoinositide 3-phosphate phosphatase. In the PTEN(-/-) UM-UC-3 bladder carcinoma cell line grown in suspension, transfected PKCdelta no longer accumulates in a dephospho-form on serum removal. By contrast, in a UM-UC-3-derivative cell line stably expressing PTEN, PKCdelta does become dephosphorylated under these conditions. Employing the PTEN Gly(129)-->Glu mutant, which is selectively defective in lipid phosphatase activity, it was established that it is the lipid phosphatase activity that controls PKCdelta phosphorylation. The evidence indicates that PKCdelta phosphorylation and its latent activity are maintained in serum-deprived adherent cultures through integrin-matrix interactions. This control acts through a pathway involving a lipid product of PI3-kinase in a manner that can be suppressed by PTEN.


Asunto(s)
Integrina beta1/metabolismo , Isoenzimas/metabolismo , Monoéster Fosfórico Hidrolasas/metabolismo , Proteína Quinasa C/metabolismo , Proteínas Supresoras de Tumor , Línea Celular , Activación Enzimática , Humanos , Fosfohidrolasa PTEN , Fosfatidilinositol 3-Quinasas/metabolismo , Fosforilación , Proteína Quinasa C-delta
3.
Curr Biol ; 9(10): 522-9, 1999 May 20.
Artículo en Inglés | MEDLINE | ID: mdl-10339425

RESUMEN

BACKGROUND: The protein kinase C (PKC) family has been implicated in the control of many cellular functions. Although PKC isotypes are characterized by their allosteric activation, phosphorylation also plays a key role in controlling activity. In classical PKC isotypes, one of the three critical sites is a carboxy-terminal hydrophobic site also conserved in other AGC kinase subfamily members. Although this site is crucial to the control of this class of enzymes, the upstream kinase(s) has not been identified. RESULTS: A membrane-associated kinase activity that phosphorylates the hydrophobic site in PKCalpha was detected. This activity was suppressed when cells were pretreated with the immunosuppresant drug rapamycin or the phosphoinositide (Pl) 3-kinase inhibitor LY294002. These pretreatments also blocked specifically the serum-induced phosphorylation of the hydrophobic site in PKCdelta in vivo. The most highly purified hydrophobic site kinase preparations ( approximately 10,000-fold) reacted with antibodies to PKCzeta/iota. Consistent with this, rapamycin and LY294002 reduced the recovery of PKCzeta from the membrane fraction of transfected cells. An activated mutant of PKCzeta, but not wild-type PKCzeta, induced phosphorylation of the PKCdelta hydrophobic site in a rapamycin-independent manner, whereas a kinase-dead PKCzeta mutant suppressed this serum-induced phosphorylation. The immunopurified, activated mutant of PKCzeta could phosphorylate the PKCdelta hydrophobic site in vitro, whereas wild-type PKCzeta could not. CONCLUSIONS: PKCzeta is identified as a component of the upstream kinase responsible for the phosphorylation of the PKCdelta hydrophobic site in vitro and in vivo. PKCzeta can therefore control the phosphorylation of this PKCdelta site, antagonizing a rapamycin-sensitive pathway.


Asunto(s)
Proteína Quinasa C/metabolismo , Sirolimus/farmacología , Animales , Sitios de Unión , Línea Celular , Cromonas/farmacología , Inhibidores Enzimáticos/farmacología , Humanos , Morfolinas/farmacología , Inhibidores de las Quinasa Fosfoinosítidos-3 , Fosforilación , Proteína Quinasa C/química , Ratas , Serina/metabolismo , Especificidad por Sustrato
4.
Science ; 281(5385): 2042-5, 1998 Sep 25.
Artículo en Inglés | MEDLINE | ID: mdl-9748166

RESUMEN

Phosphorylation sites in members of the protein kinase A (PKA), PKG, and PKC kinase subfamily are conserved. Thus, the PKB kinase PDK1 may be responsible for the phosphorylation of PKC isotypes. PDK1 phosphorylated the activation loop sites of PKCzeta and PKCdelta in vitro and in a phosphoinositide 3-kinase (PI 3-kinase)-dependent manner in vivo in human embryonic kidney (293) cells. All members of the PKC family tested formed complexes with PDK1. PDK1-dependent phosphorylation of PKCdelta in vitro was stimulated by combined PKC and PDK1 activators. The activation loop phosphorylation of PKCdelta in response to serum stimulation of cells was PI 3-kinase-dependent and was enhanced by PDK1 coexpression.


Asunto(s)
Isoenzimas/metabolismo , Fosfatidilinositol 3-Quinasas/metabolismo , Proteína Quinasa C/metabolismo , Proteínas Serina-Treonina Quinasas/metabolismo , Proteínas Quinasas Dependientes de 3-Fosfoinosítido , Sitios de Unión , Línea Celular , Cromonas/farmacología , Activación Enzimática , Inhibidores Enzimáticos/farmacología , Humanos , Morfolinas/farmacología , Fosfatidilcolinas/farmacología , Fosfatos de Fosfatidilinositol , Fosfatidilserinas/farmacología , Fosforilación , Proteína Quinasa C beta , Proteínas Recombinantes/metabolismo , Acetato de Tetradecanoilforbol/farmacología
5.
Ann Plast Surg ; 25(2): 152-3, 1990 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-2396824

RESUMEN

A simple system for irrigating large wounds can be made for use in any operating theater or ward. This versatile system allows the surgeon to change the force, volume, and speed of different solutions with an economy of movement and a minimum of manipulation. The same bottles of solutions can be applied in more than one patient, minimizing fluid waste.


Asunto(s)
Antiinfecciosos Locales/administración & dosificación , Irrigación Terapéutica/instrumentación , Heridas y Lesiones/terapia , Diseño de Equipo , Humanos , Soluciones/administración & dosificación , Irrigación Terapéutica/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA